Brinker Capital Investments’s Wave Life Sciences WVE Stock Holding History

Brinker Capital Investments’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158K	Buy	27,126 +4,280	+19%	+$28.4K	﹤0.01%	1828
2026 Q1	$166K	Sell	22,846 -2,184	-9%	-$28.5K	﹤0.01%	1887
2025 Q4	$426K	Sell	25,030 -385	-2%	-$3.91K	﹤0.01%	1658
2025 Q3	$186K	Buy	25,415 +1,023	+4%	+$8.28K	﹤0.01%	1981
2025 Q2	$159K	Buy	24,392 +5,182	+27%	+$34.2K	﹤0.01%	1922
2025 Q1	$155K	Buy	19,210 +3,419	+22%	+$37.4K	﹤0.01%	1831
2024 Q4	$195K	Buy	15,791 +850	+6%	+$11.3K	﹤0.01%	1756
2024 Q3	$123K	Buy	+14,941	New	+$89.3K	﹤0.01%	1741

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Brinker Capital Investments's WVE Position: Q2 2026 in Review

Brinker Capital Investments increased its Wave Life Sciences (WVE) stake by 19% in Q2 2026, buying an estimated $28.4K and bringing the position to 27,126 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

Brinker Capital Investments first reported a position in WVE in Q3 2024 and has held it in 8 quarters since. The position peaked at $426K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Brinker Capital Investments held 27,126 shares of Wave Life Sciences worth $158K as of Q2 2026.
Brinker Capital Investments bought 4,280 Wave Life Sciences shares in Q2 2026, an estimated $28.4K.
Wave Life Sciences made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1828 holding.
Brinker Capital Investments first reported a position in Wave Life Sciences in Q3 2024 and has held it in 8 quarters since.
Brinker Capital Investments's Wave Life Sciences position peaked at $426K in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.